• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

妊娠期间重度原发性免疫性血小板减少症治疗效果的预测模型:在三级重症孕产妇转诊中心的一项回顾性研究

A Predictive Model for Treatment Effectiveness in Severe Primary Immune Thrombocytopenia during Pregnancy: A Retrospective Study in a Tertiary Critical Maternity Referral Center.

作者信息

Wang Chuan, He Zhihong, Lio Ka U, Shi Haoting, Wang Jieying, Zhang Yu, Zhang Ning

机构信息

Department of Obstetrics and Gynecology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China,

Department of Obstetrics and Gynecology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

出版信息

Gynecol Obstet Invest. 2025;90(2):153-164. doi: 10.1159/000541721. Epub 2024 Oct 5.

DOI:10.1159/000541721
PMID:39369706
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11965822/
Abstract

OBJECTIVES

The study aimed to identify factors influencing the severity of primary immune thrombocytopenia (ITP) during pregnancy, develop a predictive model for treatment response, and report maternal and neonatal outcomes associated with severe ITP.

DESIGN

A retrospective analysis was conducted on 155 pregnancies with severe ITP between January 2018 and April 2023 at a tertiary critical maternity referral center in Shanghai, China. Participants/Materials: The study included 155 pregnancies diagnosed with severe ITP, divided into groups based on the lowest platelet count (<30 × 109/L vs. 30-50 × 109/L) and first-line treatment response (non-response vs. response).

SETTING

The study was conducted at Renji Hospital, Shanghai Jiao Tong University School of Medicine, a tertiary critical maternity rescue referral center.

METHODS

Clinical characteristics and outcomes were compared between groups. A multivariable logistic regression model was used to identify factors associated with the severity of ITP. A prediction model for treatment response was established using LASSO-logistic regression and internally validated.

RESULTS

ITP severity was found to be correlated with low maximum amplitude of thromboelastography (OR 5.43, 95% CI: 1.48-16.00, p = 0.002), bleeding events (OR 4.91, 95% CI: 1.62-14.86, p = 0.005), and low reticulocytes (OR 2.40 × 10-7, 95% CI: 1.06 × 10-13 to 0.55, p = 0.04). Of the 118 patients who received first-line therapy, 52 (44%) responded. The dataset was randomly split into a training (N = 99) and test (N = 23) set with a ratio of 8:2. A predictive nomogram was created and internally validated showing good discrimination. The model yielded an area under receiver operating characteristic curve of 0.78 (0.69-0.87) and 0.85 (0.67-1.00) in the training and validation cohort, respectively. Earlier delivery and high rate of neonatal intensive care unit admission occurred with severe ITP and treatment failure.

LIMITATIONS

The study was limited by a relatively small sample size and the retrospective observational design, which imposed limitations on the assessment of treatment efficacy.

CONCLUSIONS

We identified clinical predictors of ITP severity and treatment resistance during pregnancy. A nomogram predicting first-line response was validated. These findings can facilitate clinical decision-making and counseling regarding this challenging pregnancy complication.

OBJECTIVES

The study aimed to identify factors influencing the severity of primary immune thrombocytopenia (ITP) during pregnancy, develop a predictive model for treatment response, and report maternal and neonatal outcomes associated with severe ITP.

DESIGN

A retrospective analysis was conducted on 155 pregnancies with severe ITP between January 2018 and April 2023 at a tertiary critical maternity referral center in Shanghai, China. Participants/Materials: The study included 155 pregnancies diagnosed with severe ITP, divided into groups based on the lowest platelet count (<30 × 109/L vs. 30-50 × 109/L) and first-line treatment response (non-response vs. response).

SETTING

The study was conducted at Renji Hospital, Shanghai Jiao Tong University School of Medicine, a tertiary critical maternity rescue referral center.

METHODS

Clinical characteristics and outcomes were compared between groups. A multivariable logistic regression model was used to identify factors associated with the severity of ITP. A prediction model for treatment response was established using LASSO-logistic regression and internally validated.

RESULTS

ITP severity was found to be correlated with low maximum amplitude of thromboelastography (OR 5.43, 95% CI: 1.48-16.00, p = 0.002), bleeding events (OR 4.91, 95% CI: 1.62-14.86, p = 0.005), and low reticulocytes (OR 2.40 × 10-7, 95% CI: 1.06 × 10-13 to 0.55, p = 0.04). Of the 118 patients who received first-line therapy, 52 (44%) responded. The dataset was randomly split into a training (N = 99) and test (N = 23) set with a ratio of 8:2. A predictive nomogram was created and internally validated showing good discrimination. The model yielded an area under receiver operating characteristic curve of 0.78 (0.69-0.87) and 0.85 (0.67-1.00) in the training and validation cohort, respectively. Earlier delivery and high rate of neonatal intensive care unit admission occurred with severe ITP and treatment failure.

LIMITATIONS

The study was limited by a relatively small sample size and the retrospective observational design, which imposed limitations on the assessment of treatment efficacy.

CONCLUSIONS

We identified clinical predictors of ITP severity and treatment resistance during pregnancy. A nomogram predicting first-line response was validated. These findings can facilitate clinical decision-making and counseling regarding this challenging pregnancy complication.

摘要

目的

本研究旨在确定影响妊娠期原发性免疫性血小板减少症(ITP)严重程度的因素,建立治疗反应预测模型,并报告与严重ITP相关的母婴结局。

设计

对2018年1月至2023年4月在中国上海一家三级重症产科转诊中心的155例重度ITP妊娠进行回顾性分析。参与者/材料:该研究纳入155例诊断为重度ITP的妊娠,根据最低血小板计数(<30×10⁹/L与30 - 50×10⁹/L)和一线治疗反应(无反应与有反应)分组。

地点

该研究在上海交通大学医学院附属仁济医院进行,这是一家三级重症产科急救转诊中心。

方法

比较各组的临床特征和结局。使用多变量逻辑回归模型确定与ITP严重程度相关的因素。使用LASSO逻辑回归建立治疗反应预测模型并进行内部验证。

结果

发现ITP严重程度与血栓弹力图最大振幅降低(比值比5.43,95%置信区间:1.48 - 16.00,p = 0.002)、出血事件(比值比4.91,95%置信区间:1.62 - 14.86,p = 0.005)和网织红细胞降低(比值比2.40×10⁻⁷,95%置信区间:1.06×10⁻¹³至0.55,p = 0.04)相关。在118例接受一线治疗的患者中,52例(44%)有反应。数据集以8:2的比例随机分为训练集(N = 99)和测试集(N = 23)。创建了一个预测列线图并进行内部验证,显示出良好的区分度。该模型在训练队列和验证队列中的受试者操作特征曲线下面积分别为0.78(0.69 - 0.87)和0.85(0.67 - 1.00)。重度ITP和治疗失败会导致早产和新生儿重症监护病房入住率升高。

局限性

本研究受样本量相对较小和回顾性观察设计的限制,这对治疗效果的评估造成了局限性。

结论

我们确定了妊娠期ITP严重程度和治疗抵抗的临床预测因素。验证了预测一线反应的列线图。这些发现有助于针对这种具有挑战性的妊娠并发症进行临床决策和咨询。

目的

本研究旨在确定影响妊娠期原发性免疫性血小板减少症(ITP)严重程度的因素,建立治疗反应预测模型,并报告与严重ITP相关的母婴结局。

设计

对2018年1月至2023年4月在中国上海一家三级重症产科转诊中心的155例重度ITP妊娠进行回顾性分析。参与者/材料:该研究纳入155例诊断为重度ITP的妊娠,根据最低血小板计数(<30×10⁹/L与30 - 50×10⁹/L)和一线治疗反应(无反应与有反应)分组。

地点

该研究在上海交通大学医学院附属仁济医院进行,这是一家三级重症产科急救转诊中心。

方法

比较各组的临床特征和结局。使用多变量逻辑回归模型确定与ITP严重程度相关的因素。使用LASSO逻辑回归建立治疗反应预测模型并进行内部验证。

结果

发现ITP严重程度与血栓弹力图最大振幅降低(比值比5.43,95%置信区间:1.48 - 16.00,p = 0.002)、出血事件(比值比4.91,95%置信区间:1.62 - 14.86,p = 0.005)和网织红细胞降低(比值比2.40×10⁻⁷,95%置信区间:1.06×10⁻¹³至0.55,p = 0.04)相关。在118例接受一线治疗的患者中,52例(44%)有反应。数据集以8:2的比例随机分为训练集(N = 99)和测试集(N = 23)。创建了一个预测列线图并进行内部验证,显示出良好的区分度。该模型在训练队列和验证队列中的受试者操作特征曲线下面积分别为0.78(0.69 - 0.87)和0.85(0.67 - 1.00)。重度ITP和治疗失败会导致早产和新生儿重症监护病房入住率升高。

局限性

本研究受样本量相对较小和回顾性观察设计的限制,这对治疗效果的评估造成了局限性。

结论

我们确定了妊娠期ITP严重程度和治疗抵抗的临床预测因素。验证了预测一线反应的列线图。这些发现有助于针对这种具有挑战性的妊娠并发症进行临床决策和咨询。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9bc/11965822/3c4940778f79/goi-2025-0090-0002-541721_F04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9bc/11965822/5431ca5fa06d/goi-2025-0090-0002-541721_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9bc/11965822/8b83f4ac47d3/goi-2025-0090-0002-541721_F02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9bc/11965822/27b9e9d6df23/goi-2025-0090-0002-541721_F03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9bc/11965822/3c4940778f79/goi-2025-0090-0002-541721_F04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9bc/11965822/5431ca5fa06d/goi-2025-0090-0002-541721_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9bc/11965822/8b83f4ac47d3/goi-2025-0090-0002-541721_F02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9bc/11965822/27b9e9d6df23/goi-2025-0090-0002-541721_F03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9bc/11965822/3c4940778f79/goi-2025-0090-0002-541721_F04.jpg

相似文献

1
A Predictive Model for Treatment Effectiveness in Severe Primary Immune Thrombocytopenia during Pregnancy: A Retrospective Study in a Tertiary Critical Maternity Referral Center.妊娠期间重度原发性免疫性血小板减少症治疗效果的预测模型:在三级重症孕产妇转诊中心的一项回顾性研究
Gynecol Obstet Invest. 2025;90(2):153-164. doi: 10.1159/000541721. Epub 2024 Oct 5.
2
Impact of pre-delivery medication treatment on delivery outcome in patients with primary immune thrombocytopenia: a cohort study.预先药物治疗对原发性免疫性血小板减少症患者分娩结局的影响:一项队列研究。
Platelets. 2024 Dec;35(1):2380366. doi: 10.1080/09537104.2024.2380366. Epub 2024 Aug 1.
3
Risk factors associated with neonatal thrombocytopenia in pregnant women with immune thrombocytopenic purpura.与免疫性血小板减少性紫癜孕妇相关的新生儿血小板减少症的风险因素。
J Matern Fetal Neonatal Med. 2020 May;33(9):1572-1578. doi: 10.1080/14767058.2018.1523891. Epub 2018 Nov 4.
4
Prediction of postpartum hemorrhage in pregnant women with immune thrombocytopenia: Development and validation of the MONITOR model in a nationwide multicenter study.预测免疫性血小板减少症孕妇产后出血:一项全国多中心研究中 MONITOR 模型的建立和验证。
Am J Hematol. 2021 May 1;96(5):561-570. doi: 10.1002/ajh.26134. Epub 2021 Mar 7.
5
Clinical characteristics, neonatal risk and recurrence rate of gestational thrombocytopenia with platelet count <100 × 10/L.血小板计数<100×10⁹/L的妊娠期血小板减少症的临床特征、新生儿风险及复发率
Eur J Obstet Gynecol Reprod Biol. 2018 Dec;231:75-79. doi: 10.1016/j.ejogrb.2018.10.026. Epub 2018 Oct 10.
6
Perinatal outcomes in pregnant women with ITP: a single tertiary center experience.妊娠合并 ITP 的围产结局:单中心经验。
J Perinat Med. 2024 Jul 22;52(8):831-836. doi: 10.1515/jpm-2024-0120. Print 2024 Oct 28.
7
Effect of pregnancy on the course of immune thrombocytopenia: a retrospective study of 118 pregnancies in 82 women.妊娠对免疫性血小板减少症病程的影响:82 例女性 118 次妊娠的回顾性研究。
Br J Haematol. 2014 Sep;166(6):929-35. doi: 10.1111/bjh.12976. Epub 2014 Jun 24.
8
[Clinical analysis of pregnancy complicated with severe thrombocytopenia].妊娠合并严重血小板减少症的临床分析
Zhonghua Fu Chan Ke Za Zhi. 2010 Jun;45(6):401-5.
9
Immune Thrombocytopenic Purpura and Maternal and Neonatal Outcomes During Pregnancy: A Systematic Review and Meta-Analysis.免疫性血小板减少性紫癜与妊娠期间母婴结局:系统评价和荟萃分析。
Am J Reprod Immunol. 2024 Nov;92(5):e70008. doi: 10.1111/aji.70008.
10
Obstetric and neonatal outcomes of immune thrombocytopenic purpura in pregnancy and the role of delta hemoglobin index: A case-control study from a tertiary center.妊娠合并免疫性血小板减少症的产科和新生儿结局及 delta 血红蛋白指数的作用:来自一家三级中心的病例对照研究。
J Obstet Gynaecol Res. 2024 Dec;50(12):2246-2254. doi: 10.1111/jog.16133. Epub 2024 Oct 22.

本文引用的文献

1
Clinical significance of antinuclear antibodies in primary immune thrombocytopenia.抗核抗体在原发性免疫性血小板减少症中的临床意义。
Br J Haematol. 2023 Oct;203(1):131-135. doi: 10.1111/bjh.19069. Epub 2023 Aug 30.
2
Prognostic factors for the development of systemic lupus erythematosus in patients with immune thrombocytopenia.免疫性血小板减少症患者发生系统性红斑狼疮的预后因素。
Arthritis Res Ther. 2022 Sep 6;24(1):213. doi: 10.1186/s13075-022-02901-y.
3
A Comprehensive Review of Thrombocytopenia With a Spotlight on Intensive Care Patients.
血小板减少症综合综述:聚焦重症监护患者
Cureus. 2022 Aug 5;14(8):e27718. doi: 10.7759/cureus.27718. eCollection 2022 Aug.
4
CREST: clinical bleeding and risk evaluation in hematology-oncology patients: a systematic review and meta-analysis of thromboelastography's role.CREST:血液病-肿瘤患者临床出血及风险评估:血栓弹力描记术作用的系统评价和荟萃分析。
Blood Coagul Fibrinolysis. 2022 Oct 1;33(7):351-363. doi: 10.1097/MBC.0000000000001141. Epub 2022 Aug 12.
5
Prednisone plus IVIg compared with prednisone or IVIg for immune thrombocytopenia in pregnancy: a national retrospective cohort study.泼尼松联合静脉注射免疫球蛋白与泼尼松或静脉注射免疫球蛋白治疗妊娠期免疫性血小板减少症的全国性回顾性队列研究。
Ther Adv Hematol. 2022 Apr 29;13:20406207221095226. doi: 10.1177/20406207221095226. eCollection 2022.
6
Diagnostic Ideas and Management Strategies for Thrombocytopenia of Unknown Causes in Pregnancy.妊娠不明原因血小板减少症的诊断思路与管理策略
Front Surg. 2022 Apr 6;9:799826. doi: 10.3389/fsurg.2022.799826. eCollection 2022.
7
[Chinese guideline on the diagnosis and management of adult primary immune thrombocytopenia (version 2020)].《成人原发性免疫性血小板减少症诊断与治疗中国指南(2020年版)》
Zhonghua Xue Ye Xue Za Zhi. 2020 Aug 14;41(8):617-623. doi: 10.3760/cma.j.issn.0253-2727.2020.08.001.
8
Severe thrombocytopenia in pregnancy: a retrospective study.妊娠严重血小板减少症:一项回顾性研究。
Blood Coagul Fibrinolysis. 2020 Dec;31(8):517-521. doi: 10.1097/MBC.0000000000000955.
9
Severe thrombocytopenia in pregnancy: a case series from west China.妊娠严重血小板减少症:来自中国西部的病例系列。
Clin Exp Med. 2019 Nov;19(4):495-503. doi: 10.1007/s10238-019-00575-6. Epub 2019 Aug 28.
10
Managing ITP and thrombocytopenia in pregnancy.妊娠期间 ITP 和血小板减少症的管理。
Platelets. 2020;31(3):300-306. doi: 10.1080/09537104.2019.1640870. Epub 2019 Jul 11.